# Progesterone-driven stabilization of hybrid E/M states in amniotic epithelial cells enhances regeneration and immune modulatory capacities

**Authors:** Angelo Canciello, Alberto Maria Crovace, Verdiana Di Giulio, Giuseppe Prencipe, Mohammad El Khatib, Valentina Russo, Marta Guadalupi, Annunziata Mauro, Antonio Crovace, Oriana Di Giacinto, Maura Turriani, Laura Pierdomenico, Marco Marchisio, Barbara Barboni

PMC · DOI: 10.1016/j.isci.2026.114867 · iScience · 2026-01-31

## TL;DR

Progesterone helps amniotic cells maintain a hybrid state that boosts their ability to regenerate tissues and control immune responses.

## Contribution

This study reveals that progesterone stabilizes hybrid epithelial/mesenchymal states in amniotic cells, enhancing their regenerative and immunomodulatory functions.

## Key findings

- Progesterone delays epithelial-mesenchymal transition and promotes hybrid E/M phenotypes in amniotic epithelial cells.
- Hybrid cells show improved collective migration, stemness, and immunomodulation in vitro and in vivo.
- Transplantation of hybrid cells accelerates tendon healing and modulates macrophage polarization in an ovine model.

## Abstract

Epithelial-mesenchymal plasticity (EMP) plays a pivotal role in development, regeneration, and disease progression. In this study, we demonstrate that progesterone (P4) delays EMP in amniotic epithelial cells (AECs), promoting the emergence of hybrid epithelial/mesenchymal (E/M) phenotypes. These hybrid cells co-express E and M traits and exhibit distinct surface markers. Compared to fully M, hybrid AECs display enhanced collective migration, upregulation of stemness transcription factors, and enhanced immunomodulatory properties in vitro and in vivo. Their regenerative potential was validated by in vitro tendon differentiation on PLGA-fleeces and in an ovine tendon injury model, where the transplantation of hybrid AECs accelerated early regeneration. This effect was associated with a timely transition from inflammation to proliferation, mediated by macrophage polarization and extracellular matrix remodeling. Our findings reveal that P4 maintains AECs in a functionally hybrid E/M state, conferring regenerative and immunomodulatory advantages. These results offer insights into the physiological regulation of EMP and support the therapeutic relevance of hybrid AECs as promising candidates for cell-based regenerative medicine therapy.

•P4 delays EMT and promotes the emergence of AECs with hybrid E/M phenotypes•Hybrid AECs show enhanced stemness, differentiation, and collective migration•In vivo, hybrid AECs accelerate tendon healing and modulate macrophage polarization•Hybrid phenotypes offer a new framework for EMP-based cell therapies

P4 delays EMT and promotes the emergence of AECs with hybrid E/M phenotypes

Hybrid AECs show enhanced stemness, differentiation, and collective migration

In vivo, hybrid AECs accelerate tendon healing and modulate macrophage polarization

Hybrid phenotypes offer a new framework for EMP-based cell therapies

Molecular biology; Immunology; Developmental biology

## Linked entities

- **Chemicals:** progesterone (PubChem CID 5994)

## Full-text entities

- **Genes:** PGRMC1 (progesterone receptor membrane component 1) [NCBI Gene 10857] {aka Dap1, HPR6.6, IZA, MPR}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}, JAG1 (jagged canonical Notch ligand 1) [NCBI Gene 182] {aka AGS, AGS1, AHD, AWS, CD339, CMT2HH}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, MAEA (macrophage erythroblast attacher, E3 ubiquitin ligase) [NCBI Gene 10296] {aka EMLP, EMP, GID9, HLC-10, P44EMLP, PIG5}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, VIM (vimentin) [NCBI Gene 7431], SCX (scleraxis bHLH transcription factor) [NCBI Gene 642658] {aka SCXA, SCXB, bHLHa48}, PGRMC2 (progesterone receptor membrane component 2) [NCBI Gene 10424] {aka DG6, PMBP}, ITGB3 (integrin subunit beta 3) [NCBI Gene 3690] {aka BDPLT16, BDPLT2, BDPLT24, CD61, FMAIT1, GP3A}, Tnmd (tenomodulin) [NCBI Gene 64103] {aka 1110017I01Rik, Bricd4, ChM1L, TeM}, Atp9b (ATPase, class II, type 9B) [NCBI Gene 50771] {aka Atpc2b, IIb, MMR}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, LBR (lamin B receptor) [NCBI Gene 3930] {aka C14SR, DHCR14B, LMN2R, PHA, PHASK, TDRD18}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, NANOG (Nanog homeobox) [NCBI Gene 79923], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, Vwf (Von Willebrand factor) [NCBI Gene 22371] {aka 6820430P06Rik, B130011O06Rik, C630030D09, F8VWF, VWD}, ITGAV (integrin subunit alpha V) [NCBI Gene 3685] {aka CD51, IDNDC, MSK8, VNRA, VTNR}, TUBA1B (tubulin alpha 1b) [NCBI Gene 10376] {aka K-ALPHA-1}, TWIST1 (twist family bHLH transcription factor 1) [NCBI Gene 7291] {aka ACS3, BPES2, BPES3, CRS, CRS1, CSO}, CD86 (CD86 molecule) [NCBI Gene 942] {aka B7-2, B7.2, B70, BU63, CD28LG2, CD86 v6}, TNMD (tenomodulin) [NCBI Gene 64102] {aka BRICD4, CHM1L, TEM}
- **Diseases:** hemorrhage (MESH:D006470), edema (MESH:D004487), cancer (MESH:D009369), pain (MESH:D010146), fibrosis (MESH:D005355), inflammation (MESH:D007249), M (MESH:C566367), weight loss (MESH:D015431), Achilles tendon injury (MESH:D013708), tumorigenic (MESH:D002471), metastasis (MESH:D009362)
- **Chemicals:** hexafluoro-2-propanol (MESH:C001337), ethanol (MESH:D000431), Progesterone (MESH:D011374), Propofol (MESH:D015742), alpha-MEM (MESH:C420642), Mifepristone (MESH:D015735), diazepam (MESH:D003975), streptomycin (MESH:D013307), polymer (MESH:D011108), Triton X-100 (MESH:D017830), nitrogen (MESH:D009584), DPBS (MESH:C012939), PTFE (MESH:D011138), Midazolam (MESH:D008874), trypan blue (MESH:D014343), AIC (MESH:D000620), AG-205 (MESH:C000626467), DAPI (MESH:C007293), P4 (MESH:C015586), buprenorphine (MESH:D002047), PLGA (MESH:D000077182), PBS (MESH:D007854), Tween 20 (MESH:D011136), Poly(lactide-co-glycolide) (MESH:D011098), LPS (MESH:D008070), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), CO2 (MESH:D002245), L-Glutamine (MESH:D005973), Alexa Fluor 488 (MESH:C000711379), 4-pregnene-3,20-dione (MESH:C485330), PKH26 (MESH:C070080), Amphotericin B (MESH:D000666), penicillin (MESH:D010406), lidocaine (MESH:D008012), AEC (-)
- **Species:** Ovis aries (domestic sheep, species) [taxon 9940], Mycoplasma (genus) [taxon 2093], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933622/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933622/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933622/full.md

---
Source: https://tomesphere.com/paper/PMC12933622